New depression drug put to the test – but study stopped early
NCT ID NCT06618118
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 31 times
Summary
This study tested a new medicine, fosigotifator, for adults with major depressive disorder. About 106 people were planned to take either the drug or a placebo for around 144 days to see if it was safe and helped with depression symptoms. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel CNR /ID# 265866
Sherman Oaks, California, 91403, United States
-
CenExel iResearch, LLC /ID# 265886
Decatur, Georgia, 30030-3440, United States
-
Clinical Neuroscience Solutions - Orlando - East South Street /ID# 265060
Orlando, Florida, 32801, United States
-
Northwest Clinical Research Center /ID# 265057
Bellevue, Washington, 98007, United States
Conditions
Explore the condition pages connected to this study.